TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Opioid Drugs Market, Global Outlook and Forecast 2025-2032

Opioid Drugs Market, Global Outlook and Forecast 2025-2032

  • Category:Life Sciences
  • Published on : 07 January 2025
  • Pages :120
  • Formats:
  • Report Code:SMR-8026512

Report Overview

Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.

 

The global Opioid Drugs market size was estimated at USD 10050 million in 2023 and is projected to reach USD 16271.90 million by 2032, exhibiting a CAGR of 5.50% during the forecast period.

 

North America Opioid Drugs market size was estimated at USD 2871.47 million in 2023, at a CAGR of 4.71% during the forecast period of 2025 through 2032.

 

This report provides a deep insight into the global Opioid Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

 

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Opioid Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Opioid Drugs market in any manner.

Global Opioid Drugs Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Acura Pharmaceuticals Cipher Pharmaceutical Inc. Daiichi Sankyo Johnson?Johnson Lupin Limited Pfizer Sun Pharmaceuticals Teva Pharmaceutical Industries Ltd. Market Segmentation (

By Type

) Buprenorphine Fentanyl Hydrocodone Morphine Oxycodone Tramadol Others Market Segmentation (

By Application

) Anesthesia Pain relief Cough suppression Diarrhea suppression Deaddiction Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

 

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Opioid Drugs Market

Overview of the regional outlook of the Opioid Drugs Market:

 

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

 

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Opioid Drugs Market and its likely evolution in the short to mid-term, and long term.

 

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

 

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

 

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

 

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

 

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

 

Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

 

Chapter 9 shares the main producing countries of Opioid Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

 

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

 

Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.

 

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.

 

Chapter 13 is the main points and conclusions of the report.

TABLE OF CONTENTS

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Opioid Drugs
1.2 Key Market Segments
1.2.1 Opioid Drugs Segment by Type
1.2.2 Opioid Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Opioid Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Opioid Drugs Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Opioid Drugs Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Opioid Drugs Market Competitive Landscape
3.1 Global Opioid Drugs Sales by Manufacturers (2019-2025)
3.2 Global Opioid Drugs Revenue Market Share by Manufacturers (2019-2025)
3.3 Opioid Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Opioid Drugs Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Opioid Drugs Sales Sites, Area Served, Product Type
3.6 Opioid Drugs Market Competitive Situation and Trends
3.6.1 Opioid Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Opioid Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Opioid Drugs Industry Chain Analysis
4.1 Opioid Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Opioid Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Opioid Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Opioid Drugs Sales Market Share by Type (2019-2025)
6.3 Global Opioid Drugs Market Size Market Share by Type (2019-2025)
6.4 Global Opioid Drugs Price by Type (2019-2025)
7 Opioid Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Opioid Drugs Market Sales by Application (2019-2025)
7.3 Global Opioid Drugs Market Size (M USD) by Application (2019-2025)
7.4 Global Opioid Drugs Sales Growth Rate by Application (2019-2025)
8 Opioid Drugs Market Consumption by Region
8.1 Global Opioid Drugs Sales by Region
8.1.1 Global Opioid Drugs Sales by Region
8.1.2 Global Opioid Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Opioid Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Opioid Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Opioid Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Opioid Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Opioid Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Opioid Drugs Market Production by Region
9.1 Global Production of Opioid Drugs by Region (2019-2025)
9.2 Global Opioid Drugs Revenue Market Share by Region (2019-2025)
9.3 Global Opioid Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Opioid Drugs Production
9.4.1 North America Opioid Drugs Production Growth Rate (2019-2025)
9.4.2 North America Opioid Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Opioid Drugs Production
9.5.1 Europe Opioid Drugs Production Growth Rate (2019-2025)
9.5.2 Europe Opioid Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Opioid Drugs Production (2019-2025)
9.6.1 Japan Opioid Drugs Production Growth Rate (2019-2025)
9.6.2 Japan Opioid Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Opioid Drugs Production (2019-2025)
9.7.1 China Opioid Drugs Production Growth Rate (2019-2025)
9.7.2 China Opioid Drugs Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Acura Pharmaceuticals
10.1.1 Acura Pharmaceuticals Opioid Drugs Basic Information
10.1.2 Acura Pharmaceuticals Opioid Drugs Product Overview
10.1.3 Acura Pharmaceuticals Opioid Drugs Product Market Performance
10.1.4 Acura Pharmaceuticals Business Overview
10.1.5 Acura Pharmaceuticals Opioid Drugs SWOT Analysis
10.1.6 Acura Pharmaceuticals Recent Developments
10.2 Cipher Pharmaceutical Inc.
10.2.1 Cipher Pharmaceutical Inc. Opioid Drugs Basic Information
10.2.2 Cipher Pharmaceutical Inc. Opioid Drugs Product Overview
10.2.3 Cipher Pharmaceutical Inc. Opioid Drugs Product Market Performance
10.2.4 Cipher Pharmaceutical Inc. Business Overview
10.2.5 Cipher Pharmaceutical Inc. Opioid Drugs SWOT Analysis
10.2.6 Cipher Pharmaceutical Inc. Recent Developments
10.3 Daiichi Sankyo
10.3.1 Daiichi Sankyo Opioid Drugs Basic Information
10.3.2 Daiichi Sankyo Opioid Drugs Product Overview
10.3.3 Daiichi Sankyo Opioid Drugs Product Market Performance
10.3.4 Daiichi Sankyo Opioid Drugs SWOT Analysis
10.3.5 Daiichi Sankyo Business Overview
10.3.6 Daiichi Sankyo Recent Developments
10.4 Johnson?Johnson
10.4.1 Johnson?Johnson Opioid Drugs Basic Information
10.4.2 Johnson?Johnson Opioid Drugs Product Overview
10.4.3 Johnson?Johnson Opioid Drugs Product Market Performance
10.4.4 Johnson?Johnson Business Overview
10.4.5 Johnson?Johnson Recent Developments
10.5 Lupin Limited
10.5.1 Lupin Limited Opioid Drugs Basic Information
10.5.2 Lupin Limited Opioid Drugs Product Overview
10.5.3 Lupin Limited Opioid Drugs Product Market Performance
10.5.4 Lupin Limited Business Overview
10.5.5 Lupin Limited Recent Developments
10.6 Pfizer
10.6.1 Pfizer Opioid Drugs Basic Information
10.6.2 Pfizer Opioid Drugs Product Overview
10.6.3 Pfizer Opioid Drugs Product Market Performance
10.6.4 Pfizer Business Overview
10.6.5 Pfizer Recent Developments
10.7 Sun Pharmaceuticals
10.7.1 Sun Pharmaceuticals Opioid Drugs Basic Information
10.7.2 Sun Pharmaceuticals Opioid Drugs Product Overview
10.7.3 Sun Pharmaceuticals Opioid Drugs Product Market Performance
10.7.4 Sun Pharmaceuticals Business Overview
10.7.5 Sun Pharmaceuticals Recent Developments
10.8 Teva Pharmaceutical Industries Ltd.
10.8.1 Teva Pharmaceutical Industries Ltd. Opioid Drugs Basic Information
10.8.2 Teva Pharmaceutical Industries Ltd. Opioid Drugs Product Overview
10.8.3 Teva Pharmaceutical Industries Ltd. Opioid Drugs Product Market Performance
10.8.4 Teva Pharmaceutical Industries Ltd. Business Overview
10.8.5 Teva Pharmaceutical Industries Ltd. Recent Developments
11 Opioid Drugs Market Forecast by Region
11.1 Global Opioid Drugs Market Size Forecast
11.2 Global Opioid Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Opioid Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Opioid Drugs Market Size Forecast by Region
11.2.4 South America Opioid Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Opioid Drugs by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Opioid Drugs Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Opioid Drugs by Type (2025-2032)
12.1.2 Global Opioid Drugs Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Opioid Drugs by Type (2025-2032)
12.2 Global Opioid Drugs Market Forecast by Application (2025-2032)
12.2.1 Global Opioid Drugs Sales (K MT) Forecast by Application
12.2.2 Global Opioid Drugs Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings

LIST OF TABLES & FIGURES

List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Opioid Drugs Market Size Comparison by Region (M USD)
Table 5. Global Opioid Drugs Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Opioid Drugs Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Opioid Drugs Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Opioid Drugs Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Drugs as of 2022)
Table 10. Global Market Opioid Drugs Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Opioid Drugs Sales Sites and Area Served
Table 12. Manufacturers Opioid Drugs Product Type
Table 13. Global Opioid Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Opioid Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Opioid Drugs Market Challenges
Table 22. Global Opioid Drugs Sales by Type (K MT)
Table 23. Global Opioid Drugs Market Size by Type (M USD)
Table 24. Global Opioid Drugs Sales (K MT) by Type (2019-2025)
Table 25. Global Opioid Drugs Sales Market Share by Type (2019-2025)
Table 26. Global Opioid Drugs Market Size (M USD) by Type (2019-2025)
Table 27. Global Opioid Drugs Market Size Share by Type (2019-2025)
Table 28. Global Opioid Drugs Price (USD/MT) by Type (2019-2025)
Table 29. Global Opioid Drugs Sales (K MT) by Application
Table 30. Global Opioid Drugs Market Size by Application
Table 31. Global Opioid Drugs Sales by Application (2019-2025) & (K MT)
Table 32. Global Opioid Drugs Sales Market Share by Application (2019-2025)
Table 33. Global Opioid Drugs Sales by Application (2019-2025) & (M USD)
Table 34. Global Opioid Drugs Market Share by Application (2019-2025)
Table 35. Global Opioid Drugs Sales Growth Rate by Application (2019-2025)
Table 36. Global Opioid Drugs Sales by Region (2019-2025) & (K MT)
Table 37. Global Opioid Drugs Sales Market Share by Region (2019-2025)
Table 38. North America Opioid Drugs Sales by Country (2019-2025) & (K MT)
Table 39. Europe Opioid Drugs Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Opioid Drugs Sales by Region (2019-2025) & (K MT)
Table 41. South America Opioid Drugs Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Opioid Drugs Sales by Region (2019-2025) & (K MT)
Table 43. Global Opioid Drugs Production (K MT) by Region (2019-2025)
Table 44. Global Opioid Drugs Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Opioid Drugs Revenue Market Share by Region (2019-2025)
Table 46. Global Opioid Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Opioid Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Opioid Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Opioid Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Opioid Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Acura Pharmaceuticals Opioid Drugs Basic Information
Table 52. Acura Pharmaceuticals Opioid Drugs Product Overview
Table 53. Acura Pharmaceuticals Opioid Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Acura Pharmaceuticals Business Overview
Table 55. Acura Pharmaceuticals Opioid Drugs SWOT Analysis
Table 56. Acura Pharmaceuticals Recent Developments
Table 57. Cipher Pharmaceutical Inc. Opioid Drugs Basic Information
Table 58. Cipher Pharmaceutical Inc. Opioid Drugs Product Overview
Table 59. Cipher Pharmaceutical Inc. Opioid Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Cipher Pharmaceutical Inc. Business Overview
Table 61. Cipher Pharmaceutical Inc. Opioid Drugs SWOT Analysis
Table 62. Cipher Pharmaceutical Inc. Recent Developments
Table 63. Daiichi Sankyo Opioid Drugs Basic Information
Table 64. Daiichi Sankyo Opioid Drugs Product Overview
Table 65. Daiichi Sankyo Opioid Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Daiichi Sankyo Opioid Drugs SWOT Analysis
Table 67. Daiichi Sankyo Business Overview
Table 68. Daiichi Sankyo Recent Developments
Table 69. Johnson?Johnson Opioid Drugs Basic Information
Table 70. Johnson?Johnson Opioid Drugs Product Overview
Table 71. Johnson?Johnson Opioid Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Johnson?Johnson Business Overview
Table 73. Johnson?Johnson Recent Developments
Table 74. Lupin Limited Opioid Drugs Basic Information
Table 75. Lupin Limited Opioid Drugs Product Overview
Table 76. Lupin Limited Opioid Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Lupin Limited Business Overview
Table 78. Lupin Limited Recent Developments
Table 79. Pfizer Opioid Drugs Basic Information
Table 80. Pfizer Opioid Drugs Product Overview
Table 81. Pfizer Opioid Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Pfizer Business Overview
Table 83. Pfizer Recent Developments
Table 84. Sun Pharmaceuticals Opioid Drugs Basic Information
Table 85. Sun Pharmaceuticals Opioid Drugs Product Overview
Table 86. Sun Pharmaceuticals Opioid Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Sun Pharmaceuticals Business Overview
Table 88. Sun Pharmaceuticals Recent Developments
Table 89. Teva Pharmaceutical Industries Ltd. Opioid Drugs Basic Information
Table 90. Teva Pharmaceutical Industries Ltd. Opioid Drugs Product Overview
Table 91. Teva Pharmaceutical Industries Ltd. Opioid Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Teva Pharmaceutical Industries Ltd. Business Overview
Table 93. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 94. Global Opioid Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 95. Global Opioid Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 96. North America Opioid Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 97. North America Opioid Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 98. Europe Opioid Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 99. Europe Opioid Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 100. Asia Pacific Opioid Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 101. Asia Pacific Opioid Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 102. South America Opioid Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 103. South America Opioid Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 104. Middle East and Africa Opioid Drugs Consumption Forecast by Country (2025-2032) & (Units)
Table 105. Middle East and Africa Opioid Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 106. Global Opioid Drugs Sales Forecast by Type (2025-2032) & (K MT)
Table 107. Global Opioid Drugs Market Size Forecast by Type (2025-2032) & (M USD)
Table 108. Global Opioid Drugs Price Forecast by Type (2025-2032) & (USD/MT)
Table 109. Global Opioid Drugs Sales (K MT) Forecast by Application (2025-2032)
Table 110. Global Opioid Drugs Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Opioid Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Opioid Drugs Market Size (M USD), 2019-2032
Figure 5. Global Opioid Drugs Market Size (M USD) (2019-2032)
Figure 6. Global Opioid Drugs Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Opioid Drugs Market Size by Country (M USD)
Figure 11. Opioid Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Opioid Drugs Revenue Share by Manufacturers in 2023
Figure 13. Opioid Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Opioid Drugs Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Opioid Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Opioid Drugs Market Share by Type
Figure 18. Sales Market Share of Opioid Drugs by Type (2019-2025)
Figure 19. Sales Market Share of Opioid Drugs by Type in 2023
Figure 20. Market Size Share of Opioid Drugs by Type (2019-2025)
Figure 21. Market Size Market Share of Opioid Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Opioid Drugs Market Share by Application
Figure 24. Global Opioid Drugs Sales Market Share by Application (2019-2025)
Figure 25. Global Opioid Drugs Sales Market Share by Application in 2023
Figure 26. Global Opioid Drugs Market Share by Application (2019-2025)
Figure 27. Global Opioid Drugs Market Share by Application in 2023
Figure 28. Global Opioid Drugs Sales Growth Rate by Application (2019-2025)
Figure 29. Global Opioid Drugs Sales Market Share by Region (2019-2025)
Figure 30. North America Opioid Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Opioid Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Opioid Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Opioid Drugs Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Opioid Drugs Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Opioid Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Opioid Drugs Sales Market Share by Country in 2023
Figure 37. Germany Opioid Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Opioid Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Opioid Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Opioid Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Opioid Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Opioid Drugs Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Opioid Drugs Sales Market Share by Region in 2023
Figure 44. China Opioid Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Opioid Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Opioid Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Opioid Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Opioid Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Opioid Drugs Sales and Growth Rate (K MT)
Figure 50. South America Opioid Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Opioid Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Opioid Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Opioid Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Opioid Drugs Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Opioid Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Opioid Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Opioid Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Opioid Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Opioid Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Opioid Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Opioid Drugs Production Market Share by Region (2019-2025)
Figure 62. North America Opioid Drugs Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Opioid Drugs Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Opioid Drugs Production (K MT) Growth Rate (2019-2025)
Figure 65. China Opioid Drugs Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Opioid Drugs Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Opioid Drugs Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Opioid Drugs Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Opioid Drugs Market Share Forecast by Type (2025-2032)
Figure 70. Global Opioid Drugs Sales Forecast by Application (2025-2032)
Figure 71. Global Opioid Drugs Market Share Forecast by Application (2025-2032)

Offer REPORT BUYING OPTIONS

USD GBP EURO YEN Single User Price
USD GBP EURO YEN Multi User Price
USD GBP EURO YEN Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount